id	sid	eid	entity	type
ajlsi-3268	1	1	1	CARDINAL
ajlsi-3268	1	2	27	CARDINAL
ajlsi-3268	1	3	american	NORP
ajlsi-3268	1	4	liposomal secukinumab	PERSON
ajlsi-3268	1	5	mohammad isreb2	PERSON
ajlsi-3268	1	6	nader ghaderi3	PERSON
ajlsi-3268	1	7	shahzad1	PERSON
ajlsi-3268	1	8	akhbari4	PERSON
ajlsi-3268	1	9	diana anderson1	PERSON
ajlsi-3268	1	10	wright3	ORG
ajlsi-3268	1	11	najafzadeh1	ORG
ajlsi-3268	2	1	4	CARDINAL
ajlsi-3268	2	2	1,	DATE
ajlsi-3268	2	3	2024	CARDINAL
ajlsi-3268	2	4	2833-1397	CARDINAL
ajlsi-3268	3	1	https://doi.org/10.54536/ajlsi.v4i1.3268 https://journals.e-palli.com/home/index.php/ajlsi	ORG
ajlsi-3268	3	2	june 24, 2024	DATE
ajlsi-3268	3	3	july 30	DATE
ajlsi-3268	3	4	2024	CARDINAL
ajlsi-3268	3	5	june 15	DATE
ajlsi-3268	3	6	2025	CARDINAL
ajlsi-3268	7	1	geno toxicity	PERSON
ajlsi-3268	9	1	secukinumab	PERSON
ajlsi-3268	9	2	2.1	CARDINAL
ajlsi-3268	9	3	2.8 µg/ml	QUANTITY
ajlsi-3268	9	4	two	CARDINAL
ajlsi-3268	10	1	secukinumab bulk	PERSON
ajlsi-3268	11	1	secukinumab	PERSON
ajlsi-3268	12	1	geno toxicity	PERSON
ajlsi-3268	12	2	secukinumab	PERSON
ajlsi-3268	13	1	kadam et al.	ORG
ajlsi-3268	13	2	2010	DATE
ajlsi-3268	19	1	rendon & schäkel	ORG
ajlsi-3268	19	2	2018	DATE
ajlsi-3268	20	1	up to 2.5%	PERCENT
ajlsi-3268	20	2	2018	DATE
ajlsi-3268	21	1	90%	PERCENT
ajlsi-3268	21	2	griffiths & barker	ORG
ajlsi-3268	21	3	2007	DATE
ajlsi-3268	23	1	1994	DATE
ajlsi-3268	23	2	chen et al.	PERSON
ajlsi-3268	23	3	2018	DATE
ajlsi-3268	26	1	three	CARDINAL
ajlsi-3268	26	2	matsuzaki & umemura	ORG
ajlsi-3268	26	3	2018	DATE
ajlsi-3268	29	1	six	CARDINAL
ajlsi-3268	29	2	il 17 (	ORG
ajlsi-3268	30	1	one	CARDINAL
ajlsi-3268	30	2	th17	PRODUCT
ajlsi-3268	31	1	1	CARDINAL
ajlsi-3268	31	2	university of bradford	ORG
ajlsi-3268	31	3	bradford	GPE
ajlsi-3268	31	4	1dp	ORDINAL
ajlsi-3268	31	5	2	CARDINAL
ajlsi-3268	31	6	university of bradford	ORG
ajlsi-3268	31	7	richmond road	GPE
ajlsi-3268	31	8	bradford	GPE
ajlsi-3268	31	9	1dp	ORDINAL
ajlsi-3268	31	10	3	CARDINAL
ajlsi-3268	31	11	nhs foundation trust	ORG
ajlsi-3268	31	12	st luke’s	PERSON
ajlsi-3268	31	13	bd5 0na	GPE
ajlsi-3268	31	14	uk 4 institute of biomedical	ORG
ajlsi-3268	31	15	university of exeter	ORG
ajlsi-3268	31	16	ex2 5dw	DATE
ajlsi-3268	31	17	uk	GPE
ajlsi-3268	31	18	28 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	32	1	j. life sci	PERSON
ajlsi-3268	32	2	innov	GPE
ajlsi-3268	33	1	4(1	CARDINAL
ajlsi-3268	34	1	27	CARDINAL
ajlsi-3268	34	2	2025	CARDINAL
ajlsi-3268	34	3	th17	PRODUCT
ajlsi-3268	35	1	th17	PRODUCT
ajlsi-3268	35	2	il-21	ORG
ajlsi-3268	35	3	il-22	CARDINAL
ajlsi-3268	36	1	il-17a	PRODUCT
ajlsi-3268	37	1	il-17a	PRODUCT
ajlsi-3268	40	1	secukinumab	PERSON
ajlsi-3268	40	2	ain457	ORG
ajlsi-3268	40	3	antiil17a	ORG
ajlsi-3268	41	1	al.	PERSON
ajlsi-3268	41	2	2013	DATE
ajlsi-3268	42	1	chinese	NORP
ajlsi-3268	42	2	igg1/k-class property	ORG
ajlsi-3268	42	3	molden et al.	PERSON
ajlsi-3268	42	4	2021	CARDINAL
ajlsi-3268	43	1	secukinumab	PERSON
ajlsi-3268	43	2	75	CARDINAL
ajlsi-3268	43	3	2021	CARDINAL
ajlsi-3268	44	1	2018	DATE
ajlsi-3268	45	1	interleukin-17a	CARDINAL
ajlsi-3268	46	1	secukinumab	PERSON
ajlsi-3268	46	2	th17	PRODUCT
ajlsi-3268	46	3	berg et al.	PERSON
ajlsi-3268	46	4	2021	CARDINAL
ajlsi-3268	47	1	th1	ORG
ajlsi-3268	49	1	th17/th22	PRODUCT
ajlsi-3268	50	1	il)-17	ORG
ajlsi-3268	50	2	il-22	CARDINAL
ajlsi-3268	50	3	ifn-γ	ORG
ajlsi-3268	50	4	lai et al.	PERSON
ajlsi-3268	50	5	2018	DATE
ajlsi-3268	50	6	ciążyńska	NORP
ajlsi-3268	50	7	2021	CARDINAL
ajlsi-3268	52	1	lombardo & kiselev	ORG
ajlsi-3268	52	2	2022	CARDINAL
ajlsi-3268	54	1	2015	DATE
ajlsi-3268	54	2	2022	CARDINAL
ajlsi-3268	57	1	1	CARDINAL
ajlsi-3268	58	1	tc17	PRODUCT
ajlsi-3268	58	2	3	CARDINAL
ajlsi-3268	59	1	29 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	60	1	j. life sci	PERSON
ajlsi-3268	60	2	innov	GPE
ajlsi-3268	61	1	4(1	CARDINAL
ajlsi-3268	62	1	27	CARDINAL
ajlsi-3268	62	2	2025	CARDINAL
ajlsi-3268	64	1	2021	DATE
ajlsi-3268	65	1	novartis	ORG
ajlsi-3268	66	1	1	CARDINAL
ajlsi-3268	66	2	2-dipalmitoyl-sn	DATE
ajlsi-3268	66	3	1,2	CARDINAL
ajlsi-3268	66	4	99%	PERCENT
ajlsi-3268	66	5	sigma-aldrich company ltd.	ORG
ajlsi-3268	66	6	uk	GPE
ajlsi-3268	67	1	aldrich u.k.	ORG
ajlsi-3268	70	1	150 mg	QUANTITY
ajlsi-3268	72	1	3:1	CARDINAL
ajlsi-3268	72	2	with1,2dipalmitoyl	GPE
ajlsi-3268	72	3	1,2	CARDINAL
ajlsi-3268	73	1	40 °	QUANTITY
ajlsi-3268	73	2	six hours	TIME
ajlsi-3268	73	3	10ml	CARDINAL
ajlsi-3268	74	1	1ml	CARDINAL
ajlsi-3268	74	2	1	CARDINAL
ajlsi-3268	74	3	60 °	QUANTITY
ajlsi-3268	74	4	150	CARDINAL
ajlsi-3268	74	5	60°	QUANTITY
ajlsi-3268	74	6	75 μg/ml	QUANTITY
ajlsi-3268	75	1	22,000 x	QUANTITY
ajlsi-3268	75	2	30 minutes	TIME
ajlsi-3268	75	3	4 °	QUANTITY
ajlsi-3268	76	1	3600	CARDINAL
ajlsi-3268	78	1	150	CARDINAL
ajlsi-3268	79	1	the leeds east research ethics committee	ORG
ajlsi-3268	79	2	12	CARDINAL
ajlsi-3268	80	1	the university of bradford	ORG
ajlsi-3268	81	1	bradford teaching hospital nhs foundation	ORG
ajlsi-3268	81	2	1202	DATE
ajlsi-3268	82	1	40	CARDINAL
ajlsi-3268	82	2	20	CARDINAL
ajlsi-3268	82	3	20	CARDINAL
ajlsi-3268	84	1	1	CARDINAL
ajlsi-3268	85	1	2	CARDINAL
ajlsi-3268	86	1	1	CARDINAL
ajlsi-3268	87	1	nc	GPE
ajlsi-3268	87	2	ge	ORG
ajlsi-3268	87	3	20 ) age 21-40	DATE
ajlsi-3268	87	4	30	CARDINAL
ajlsi-3268	87	5	35	CARDINAL
ajlsi-3268	87	6	35	CARDINAL
ajlsi-3268	87	7	9 45	DATE
ajlsi-3268	87	8	11 55	CARDINAL
ajlsi-3268	87	9	3 15	CARDINAL
ajlsi-3268	87	10	17 85	CARDINAL
ajlsi-3268	87	11	5 25	CARDINAL
ajlsi-3268	87	12	15 75	CARDINAL
ajlsi-3268	87	13	2	CARDINAL
ajlsi-3268	90	1	nc	GPE
ajlsi-3268	90	2	ge	ORG
ajlsi-3268	90	3	20 age 20-35	DATE
ajlsi-3268	90	4	10 50	CARDINAL
ajlsi-3268	90	5	10 50	PERCENT
ajlsi-3268	90	6	10 50 caucasian	PERCENT
ajlsi-3268	90	7	35	CARDINAL
ajlsi-3268	90	8	2 10	CARDINAL
ajlsi-3268	90	9	19 95	CARDINAL
ajlsi-3268	90	10	1 5	CARDINAL
ajlsi-3268	90	11	8	CARDINAL
ajlsi-3268	90	12	uk	GPE
ajlsi-3268	90	13	30 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	91	1	j. life sci	PERSON
ajlsi-3268	91	2	innov	GPE
ajlsi-3268	92	1	4(1	CARDINAL
ajlsi-3268	93	1	27	CARDINAL
ajlsi-3268	93	2	2025	DATE
ajlsi-3268	94	1	3000	CARDINAL
ajlsi-3268	96	1	≥80%	PERCENT
ajlsi-3268	97	1	20	CARDINAL
ajlsi-3268	97	2	20	CARDINAL
ajlsi-3268	97	3	10%	PERCENT
ajlsi-3268	97	4	-80 °	QUANTITY
ajlsi-3268	98	1	five	CARDINAL
ajlsi-3268	98	2	un	ORG
ajlsi-3268	98	3	nc	GPE
ajlsi-3268	98	4	1640	CARDINAL
ajlsi-3268	99	1	10μl, 75μm	DATE
ajlsi-3268	99	2	two	CARDINAL
ajlsi-3268	99	3	2.8	CARDINAL
ajlsi-3268	99	4	1000μl	ORDINAL
ajlsi-3268	100	1	3000	CARDINAL
ajlsi-3268	100	2	37°	QUANTITY
ajlsi-3268	100	3	2000	DATE
ajlsi-3268	100	4	najafzadeh & anderson	ORG
ajlsi-3268	100	5	2016	DATE
ajlsi-3268	101	1	6	CARDINAL
ajlsi-3268	101	2	belfast	GPE
ajlsi-3268	101	3	20x	CARDINAL
ajlsi-3268	101	4	ccd	ORG
ajlsi-3268	101	5	100	CARDINAL
ajlsi-3268	102	1	350	CARDINAL
ajlsi-3268	102	2	130μl of phytohaemagglutinin	ORG
ajlsi-3268	102	3	25cm3	CARDINAL
ajlsi-3268	102	4	4.5 ml	QUANTITY
ajlsi-3268	102	5	1%	PERCENT
ajlsi-3268	102	6	15%	PERCENT
ajlsi-3268	102	7	24h	DATE
ajlsi-3268	102	8	37⁰c	CARDINAL
ajlsi-3268	102	9	the existence of	DATE
ajlsi-3268	102	10	5%	PERCENT
ajlsi-3268	104	1	44h	DATE
ajlsi-3268	104	2	fenech	NORP
ajlsi-3268	104	3	2016	DATE
ajlsi-3268	105	1	40x	CARDINAL
ajlsi-3268	105	2	1000	CARDINAL
ajlsi-3268	105	3	fenech	NORP
ajlsi-3268	105	4	2007	DATE
ajlsi-3268	106	1	ndi	PERSON
ajlsi-3268	107	1	ndi =	PERSON
ajlsi-3268	108	1	+ 3(m3	DATE
ajlsi-3268	109	1	m3	CARDINAL
ajlsi-3268	109	2	fenech	NORP
ajlsi-3268	109	3	2016	DATE
ajlsi-3268	110	1	one	CARDINAL
ajlsi-3268	110	2	anova	ORG
ajlsi-3268	111	1	0.05	CARDINAL
ajlsi-3268	112	1	8	CARDINAL
ajlsi-3268	113	1	between 100 and 200	CARDINAL
ajlsi-3268	114	1	2	CARDINAL
ajlsi-3268	114	2	tem	ORG
ajlsi-3268	114	3	3	CARDINAL
ajlsi-3268	114	4	24	CARDINAL
ajlsi-3268	114	5	2.1	CARDINAL
ajlsi-3268	114	6	2.8	CARDINAL
ajlsi-3268	114	7	3.751 μg/ml	QUANTITY
ajlsi-3268	114	8	31 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	115	1	j. life sci	PERSON
ajlsi-3268	115	2	innov	GPE
ajlsi-3268	116	1	4(1	CARDINAL
ajlsi-3268	117	1	27	CARDINAL
ajlsi-3268	117	2	2025	DATE
ajlsi-3268	118	1	3	CARDINAL
ajlsi-3268	119	1	4	CARDINAL
ajlsi-3268	119	2	one	CARDINAL
ajlsi-3268	119	3	anova	ORG
ajlsi-3268	120	1	secukinumab	PERSON
ajlsi-3268	120	2	two	CARDINAL
ajlsi-3268	121	1	4	CARDINAL
ajlsi-3268	121	2	4	CARDINAL
ajlsi-3268	121	3	nc	GPE
ajlsi-3268	121	4	nc	GPE
ajlsi-3268	121	5	20	CARDINAL
ajlsi-3268	121	6	secukinumab bulk	PERSON
ajlsi-3268	121	7	4	CARDINAL
ajlsi-3268	124	1	nc	GPE
ajlsi-3268	124	2	secukinumab	GPE
ajlsi-3268	125	1	5	CARDINAL
ajlsi-3268	125	2	5	CARDINAL
ajlsi-3268	125	3	20	CARDINAL
ajlsi-3268	125	4	20	CARDINAL
ajlsi-3268	125	5	nc	GPE
ajlsi-3268	125	6	nc	GPE
ajlsi-3268	125	7	20	CARDINAL
ajlsi-3268	125	8	secukinumab bulk	PERSON
ajlsi-3268	126	1	ge	ORG
ajlsi-3268	126	2	32 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	127	1	j. life sci	PERSON
ajlsi-3268	127	2	innov	GPE
ajlsi-3268	128	1	4(1	CARDINAL
ajlsi-3268	129	1	27	CARDINAL
ajlsi-3268	129	2	2025	CARDINAL
ajlsi-3268	130	1	secukinumab 2.1µg	PERSON
ajlsi-3268	130	2	6	CARDINAL
ajlsi-3268	130	3	6	CARDINAL
ajlsi-3268	130	4	1000	CARDINAL
ajlsi-3268	130	5	5	CARDINAL
ajlsi-3268	130	6	5	CARDINAL
ajlsi-3268	130	7	n=1000	CARDINAL
ajlsi-3268	130	8	±	CARDINAL
ajlsi-3268	130	9	two	CARDINAL
ajlsi-3268	130	10	0.4µm	QUANTITY
ajlsi-3268	130	11	2.1µg	ORG
ajlsi-3268	130	12	2.1µg	ORG
ajlsi-3268	130	13	0.0001	CARDINAL
ajlsi-3268	131	1	n=5	PERSON
ajlsi-3268	131	2	5	CARDINAL
ajlsi-3268	131	3	secukinumab bulk	PERSON
ajlsi-3268	131	4	secukinumab	PERSON
ajlsi-3268	131	5	jak	PERSON
ajlsi-3268	132	1	secukinumab	PERSON
ajlsi-3268	132	2	damiani et al.	PERSON
ajlsi-3268	132	3	2022	CARDINAL
ajlsi-3268	133	1	secukinumab	PERSON
ajlsi-3268	133	2	2020	DATE
ajlsi-3268	134	1	miyagawa	ORG
ajlsi-3268	134	2	2022	CARDINAL
ajlsi-3268	134	3	2022	CARDINAL
ajlsi-3268	136	1	20	CARDINAL
ajlsi-3268	136	2	20	CARDINAL
ajlsi-3268	137	1	secukinumab	GPE
ajlsi-3268	139	1	0.001	CARDINAL
ajlsi-3268	140	1	secukinumab	PERSON
ajlsi-3268	143	1	secukinumab	GPE
ajlsi-3268	144	1	zou & meng	ORG
ajlsi-3268	144	2	2021	DATE
ajlsi-3268	148	1	2.1μg/ml	QUANTITY
ajlsi-3268	149	1	al.	GPE
ajlsi-3268	149	2	2009	DATE
ajlsi-3268	149	3	stanić et al.	PERSON
ajlsi-3268	149	4	2016	DATE
ajlsi-3268	151	1	33 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	152	1	j. life sci	PERSON
ajlsi-3268	152	2	innov	GPE
ajlsi-3268	153	1	4(1	CARDINAL
ajlsi-3268	154	1	27	CARDINAL
ajlsi-3268	154	2	2025	CARDINAL
ajlsi-3268	154	3	secukinumab	PERSON
ajlsi-3268	156	1	cck8	PERSON
ajlsi-3268	156	2	lin & huang	ORG
ajlsi-3268	156	3	2016	DATE
ajlsi-3268	157	1	two	CARDINAL
ajlsi-3268	157	2	2.1µg	CARDINAL
ajlsi-3268	157	3	2.8µg	ORG
ajlsi-3268	157	4	over 75%	PERCENT
ajlsi-3268	158	1	fenech	NORP
ajlsi-3268	158	2	2009	DATE
ajlsi-3268	165	1	magdolenova	NORP
ajlsi-3268	165	2	2012	DATE
ajlsi-3268	165	3	2010	DATE
ajlsi-3268	167	1	75 μm	QUANTITY
ajlsi-3268	168	1	un	ORG
ajlsi-3268	169	1	75 μm	QUANTITY
ajlsi-3268	171	1	first	ORDINAL
ajlsi-3268	172	1	ndi	ORG
ajlsi-3268	172	2	ndi	ORG
ajlsi-3268	173	1	secukinumab	PERSON
ajlsi-3268	174	1	2.1μg/ml	QUANTITY
ajlsi-3268	175	1	nc	GPE
ajlsi-3268	176	1	secukinumab 2.1μg/ml	PERSON
ajlsi-3268	182	1	secukinumab	GPE
ajlsi-3268	188	1	dam-age	DATE
ajlsi-3268	190	1	ge	ORG
ajlsi-3268	190	2	34 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	191	1	j. life sci	PERSON
ajlsi-3268	191	2	innov	GPE
ajlsi-3268	192	1	4(1	CARDINAL
ajlsi-3268	193	1	27	CARDINAL
ajlsi-3268	193	2	2025	CARDINAL
ajlsi-3268	193	3	secukinumab	PERSON
ajlsi-3268	194	1	secukinumab	PERSON
ajlsi-3268	195	1	university of bradford	ORG
ajlsi-3268	197	1	g. layas & m. isreb n. ghaderi & fanila	ORG
ajlsi-3268	197	2	ethica	PERSON
ajlsi-3268	197	3	akhbari	NORP
ajlsi-3268	197	4	d. andreson	PERSON
ajlsi-3268	197	5	a. wright & m. najafzadeh:	ORG
ajlsi-3268	198	1	cho chinese	NORP
ajlsi-3268	198	2	dcm methanol dichloromethane dope	ORG
ajlsi-3268	198	3	dioleoyl phsphoethanolamine	PERSON
ajlsi-3268	198	4	1,2	CARDINAL
ajlsi-3268	198	5	17	CARDINAL
ajlsi-3268	198	6	roswell park memorial institute	FAC
ajlsi-3268	198	7	j.	GPE
ajlsi-3268	198	8	a.	GPE
ajlsi-3268	198	9	nia	GPE
ajlsi-3268	198	10	j., hashim	PERSON
ajlsi-3268	198	11	m., de vera, a.	PERSON
ajlsi-3268	198	12	2021	CARDINAL
ajlsi-3268	199	1	secukinumab	PERSON
ajlsi-3268	199	2	52-week	DATE
ajlsi-3268	199	3	3b	CARDINAL
ajlsi-3268	200	1	the european academy	ORG
ajlsi-3268	200	2	135–142	CARDINAL
ajlsi-3268	201	1	berg	PERSON
ajlsi-3268	201	2	s. h.	PERSON
ajlsi-3268	201	3	balogh	PERSON
ajlsi-3268	201	4	e. a.	PERSON
ajlsi-3268	201	5	ghamrawi	GPE
ajlsi-3268	201	6	r. i.	PERSON
ajlsi-3268	201	7	s. r.	PERSON
ajlsi-3268	201	8	2021	CARDINAL
ajlsi-3268	203	1	13(3	CARDINAL
ajlsi-3268	203	2	201–216	CARDINAL
ajlsi-3268	204	1	bissonnette,	PERSON
ajlsi-3268	204	2	r.	NORP
ajlsi-3268	204	3	luger	PERSON
ajlsi-3268	204	4	d.	NORP
ajlsi-3268	204	5	toth	PERSON
ajlsi-3268	204	6	d.	NORP
ajlsi-3268	204	7	lacombe, a.	PERSON
ajlsi-3268	204	8	xia	GPE
ajlsi-3268	204	9	2018	DATE
ajlsi-3268	205	1	secukinumab	PERSON
ajlsi-3268	205	2	5 years	DATE
ajlsi-3268	206	1	the european academy	ORG
ajlsi-3268	206	2	32(9	CARDINAL
ajlsi-3268	206	3	1507–1514	CARDINAL
ajlsi-3268	207	1	c.	GPE
ajlsi-3268	207	2	wittmann	GPE
ajlsi-3268	207	3	m., macleod	PERSON
ajlsi-3268	207	4	t.	GPE
ajlsi-3268	207	5	a.	GPE
ajlsi-3268	207	6	newton	GPE
ajlsi-3268	207	7	d.	NORP
ajlsi-3268	207	8	bhan	GPE
ajlsi-3268	207	9	k.	PERSON
ajlsi-3268	207	10	2022	CARDINAL
ajlsi-3268	208	1	2	CARDINAL
ajlsi-3268	208	2	17	CARDINAL
ajlsi-3268	209	1	142(10	ORG
ajlsi-3268	209	2	2660–2667	DATE
ajlsi-3268	210	1	chen	PERSON
ajlsi-3268	210	2	deng, h.	ORG
ajlsi-3268	210	3	z.	PERSON
ajlsi-3268	210	4	deng	PERSON
ajlsi-3268	210	5	2018	DATE
ajlsi-3268	212	1	9(6	CARDINAL
ajlsi-3268	212	2	7204–7218	DATE
ajlsi-3268	213	1	ciążyńska	PERSON
ajlsi-3268	213	2	m.	PERSON
ajlsi-3268	213	3	i.	PERSON
ajlsi-3268	213	4	d.	NORP
ajlsi-3268	213	5	j.	PERSON
ajlsi-3268	213	6	skibińska	GPE
ajlsi-3268	213	7	m., & lesiak	ORG
ajlsi-3268	213	8	a.	PERSON
ajlsi-3268	213	9	2021	CARDINAL
ajlsi-3268	215	1	11(4	DATE
ajlsi-3268	215	2	326	CARDINAL
ajlsi-3268	216	1	damiani	PERSON
ajlsi-3268	216	2	pacifico, a.	ORG
ajlsi-3268	216	3	morrone	GPE
ajlsi-3268	216	4	conic	ORG
ajlsi-3268	216	5	r. r.	PERSON
ajlsi-3268	216	6	davidson	GPE
ajlsi-3268	216	7	2022	CARDINAL
ajlsi-3268	217	1	secukinumab	PERSON
ajlsi-3268	217	2	italian	NORP
ajlsi-3268	218	1	15(1	CARDINAL
ajlsi-3268	218	2	95	CARDINAL
ajlsi-3268	218	3	j. t.	PERSON
ajlsi-3268	219	1	2018	DATE
ajlsi-3268	223	1	fenech	ORG
ajlsi-3268	223	2	m.	GPE
ajlsi-3268	223	3	s.	PERSON
ajlsi-3268	223	4	s.	GPE
ajlsi-3268	223	5	holland	GPE
ajlsi-3268	223	6	n., migliore	ORG
ajlsi-3268	224	1	2016	CARDINAL
ajlsi-3268	226	1	770	CARDINAL
ajlsi-3268	227	1	fenech	ORG
ajlsi-3268	227	2	m. (	PERSON
ajlsi-3268	227	3	2007	DATE
ajlsi-3268	229	1	2(5	CARDINAL
ajlsi-3268	229	2	1084–1104	DATE
ajlsi-3268	230	1	fenech	ORG
ajlsi-3268	230	2	m.	PERSON
ajlsi-3268	230	3	2009	DATE
ajlsi-3268	232	1	681(23	CARDINAL
ajlsi-3268	232	2	111–117	CARDINAL
ajlsi-3268	233	1	griffiths	GPE
ajlsi-3268	233	2	c. e.	PERSON
ajlsi-3268	233	3	j. n.	PERSON
ajlsi-3268	233	4	2007	DATE
ajlsi-3268	235	1	lancet	ORG
ajlsi-3268	235	2	370(9583	DATE
ajlsi-3268	235	3	263–271	CARDINAL
ajlsi-3268	236	1	kadam	PERSON
ajlsi-3268	236	2	d. p.	PERSON
ajlsi-3268	236	3	suryakar	PERSON
ajlsi-3268	236	4	a. n.	PERSON
ajlsi-3268	236	5	ankush	PERSON
ajlsi-3268	236	6	r. d.	PERSON
ajlsi-3268	236	7	kadam	GPE
ajlsi-3268	236	8	k. h.	PERSON
ajlsi-3268	236	9	2010	DATE
ajlsi-3268	238	1	indian	NORP
ajlsi-3268	238	2	25	DATE
ajlsi-3268	238	3	388–392	CARDINAL
ajlsi-3268	238	4	lai	ORG
ajlsi-3268	238	5	r.	NORP
ajlsi-3268	238	6	xian	PERSON
ajlsi-3268	238	7	d.	NORP
ajlsi-3268	238	8	xiong	GPE
ajlsi-3268	238	9	x.	GPE
ajlsi-3268	238	10	yang	PERSON
ajlsi-3268	238	11	l.	PERSON
ajlsi-3268	238	12	j., & zhong	ORG
ajlsi-3268	238	13	2018	DATE
ajlsi-3268	239	1	th17	ORG
ajlsi-3268	240	1	23(1	GPE
ajlsi-3268	240	2	130–135	CARDINAL
ajlsi-3268	241	1	lin	PERSON
ajlsi-3268	241	2	x.	GPE
ajlsi-3268	241	3	t.	GPE
ajlsi-3268	241	4	2016	CARDINAL
ajlsi-3268	243	1	50(6	CARDINAL
ajlsi-3268	243	2	585–595	DATE
ajlsi-3268	244	1	d., & kiselev	ORG
ajlsi-3268	244	2	m. a.	PERSON
ajlsi-3268	244	3	2022	CARDINAL
ajlsi-3268	245	1	nanomedicine application	ORG
ajlsi-3268	246	1	pharmaceutics	ORG
ajlsi-3268	246	2	14(3	CARDINAL
ajlsi-3268	246	3	543	CARDINAL
ajlsi-3268	246	4	m. (2018	ORG
ajlsi-3268	247	1	35 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-3268	248	1	j. life sci	PERSON
ajlsi-3268	248	2	innov	GPE
ajlsi-3268	249	1	4(1	CARDINAL
ajlsi-3268	250	1	27	CARDINAL
ajlsi-3268	250	2	2025	CARDINAL
ajlsi-3268	250	3	non‐hematopoietic	NORP
ajlsi-3268	251	1	1–13	CARDINAL
ajlsi-3268	252	1	magdolenova	GPE
ajlsi-3268	252	2	z.	PERSON
ajlsi-3268	252	3	collins	PERSON
ajlsi-3268	252	4	a., & dusinska	ORG
ajlsi-3268	252	5	m.	PERSON
ajlsi-3268	252	6	2012	DATE
ajlsi-3268	254	1	800–806	CARDINAL
ajlsi-3268	255	1	miyagawa, f. (	ORG
ajlsi-3268	255	2	2022	CARDINAL
ajlsi-3268	257	1	10(7	CARDINAL
ajlsi-3268	257	2	1485	CARDINAL
ajlsi-3268	258	1	molden	GPE
ajlsi-3268	258	2	r.	NORP
ajlsi-3268	258	3	hu	PERSON
ajlsi-3268	258	4	e. s.	PERSON
ajlsi-3268	258	5	saggese	NORP
ajlsi-3268	258	6	d.	NORP
ajlsi-3268	258	7	j.	PERSON
ajlsi-3268	258	8	j.	PERSON
ajlsi-3268	259	1	2021	CARDINAL
ajlsi-3268	261	1	mabs	PERSON
ajlsi-3268	261	2	13(1	CARDINAL
ajlsi-3268	261	3	1901684	DATE
ajlsi-3268	262	1	najafzadeh	PERSON
ajlsi-3268	262	2	m., & anderson	ORG
ajlsi-3268	262	3	2016	DATE
ajlsi-3268	264	1	177–191	CARDINAL
ajlsi-3268	265	1	najafzadeh	PERSON
ajlsi-3268	265	2	m., gueidan	PERSON
ajlsi-3268	265	3	van den ende	PERSON
ajlsi-3268	265	4	a. g.	PERSON
ajlsi-3268	265	5	2009	DATE
ajlsi-3268	267	1	47(1	DATE
ajlsi-3268	267	2	17–25	CARDINAL
ajlsi-3268	268	1	nestle	ORG
ajlsi-3268	268	2	f.	PERSON
ajlsi-3268	268	3	l., & nickoloff	ORG
ajlsi-3268	268	4	1994	DATE
ajlsi-3268	269	1	th1	ORG
ajlsi-3268	270	1	94(1	CARDINAL
ajlsi-3268	270	2	202–209	CARDINAL
ajlsi-3268	271	1	nsairat	ORG
ajlsi-3268	271	2	h.	PERSON
ajlsi-3268	271	3	khater	PERSON
ajlsi-3268	271	4	d.	NORP
ajlsi-3268	271	5	sayed	GPE
ajlsi-3268	271	6	f.	PERSON
ajlsi-3268	271	7	al bawab	PERSON
ajlsi-3268	271	8	a., & alshaer	ORG
ajlsi-3268	271	9	w.	PERSON
ajlsi-3268	271	10	2022	CARDINAL
ajlsi-3268	273	1	8(2	CARDINAL
ajlsi-3268	273	2	oecd	ORG
ajlsi-3268	274	1	2010	DATE
ajlsi-3268	276	1	487	CARDINAL
ajlsi-3268	277	1	oecd	ORG
ajlsi-3268	278	1	rendon, a., & schäkel	ORG
ajlsi-3268	278	2	k.	PERSON
ajlsi-3268	278	3	2019	DATE
ajlsi-3268	280	1	20(6	CARDINAL
ajlsi-3268	280	2	1475	CARDINAL
ajlsi-3268	281	1	t.	GPE
ajlsi-3268	281	2	moheimani	ORG
ajlsi-3268	281	3	f.	PERSON
ajlsi-3268	281	4	wu	PERSON
ajlsi-3268	281	5	s. y.	PERSON
ajlsi-3268	281	6	a. k.	PERSON
ajlsi-3268	281	7	s.	PERSON
ajlsi-3268	281	8	2015	CARDINAL
ajlsi-3268	283	1	6	CARDINAL
ajlsi-3268	283	2	286	CARDINAL
ajlsi-3268	283	3	malmberg	GPE
ajlsi-3268	283	4	c.	GPE
ajlsi-3268	283	5	åkerborg	GPE
ajlsi-3268	283	6	ö.	GPE
ajlsi-3268	283	7	kumar	PERSON
ajlsi-3268	283	8	d.	NORP
ajlsi-3268	283	9	s.	PERSON
ajlsi-3268	283	10	2020	DATE
ajlsi-3268	284	1	secukinumab	PERSON
ajlsi-3268	284	2	uk	GPE
ajlsi-3268	284	3	4(4	PRODUCT
ajlsi-3268	284	4	635–648	CARDINAL
ajlsi-3268	285	1	stanić	ORG
ajlsi-3268	285	2	d.	NORP
ajlsi-3268	285	3	j.	GPE
ajlsi-3268	285	4	m.	PERSON
ajlsi-3268	285	5	kotur-stevuljević	PERSON
ajlsi-3268	285	6	j.	PERSON
ajlsi-3268	286	1	2016	CARDINAL
ajlsi-3268	288	1	chemico-biological	PERSON
ajlsi-3268	288	2	256	CARDINAL
ajlsi-3268	288	3	134–141	CARDINAL
ajlsi-3268	289	1	tice	GPE
ajlsi-3268	289	2	r. r.	PERSON
ajlsi-3268	289	3	anderson	PERSON
ajlsi-3268	289	4	d., burlinson	GPE
ajlsi-3268	289	5	b.	GPE
ajlsi-3268	289	6	hartmann	GPE
ajlsi-3268	289	7	a.	GPE
ajlsi-3268	289	8	kobayashi, h., ... & sasaki	ORG
ajlsi-3268	289	9	y. f. (	PERSON
ajlsi-3268	289	10	2000	DATE
ajlsi-3268	291	1	35(3	CARDINAL
ajlsi-3268	291	2	206–221	CARDINAL
ajlsi-3268	291	3	wagener	ORG
ajlsi-3268	291	4	f. a.	PERSON
ajlsi-3268	291	5	carels	ORG
ajlsi-3268	291	6	c. e., & lundvig	PERSON
ajlsi-3268	291	7	d. m.	PERSON
ajlsi-3268	291	8	2013	DATE
ajlsi-3268	293	1	14(5	DATE
ajlsi-3268	293	2	9126–9167	CARDINAL
ajlsi-3268	294	1	k.	PERSON
ajlsi-3268	294	2	2021	CARDINAL
ajlsi-3268	296	1	mdpi	GPE
ajlsi-3268	296	2	11(8	DATE
ajlsi-3268	296	3	5754	DATE
ajlsi-3268	297	1	meng	PERSON
ajlsi-3268	297	2	z.	PERSON
ajlsi-3268	297	3	2021	CARDINAL
ajlsi-3268	298	1	covid-19	GPE
ajlsi-3268	298	2	14	CARDINAL
ajlsi-3268	298	3	5611–5621	CARDINAL